Coherus Biosciences reported $-0.35 in EPS Earnings Per Share for its fiscal quarter ending in March of 2025.





Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Akebia Therapeutics USD 0.03 0.13 Mar/2025
ALKERMES USD 0.29 0.2 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amarin USD 0.08 0.11 Sep/2025
Amgen USD 5.29 0.35 Dec/2025
Baxter International USD 0.44 0.25 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Coherus Biosciences USD -0.35 0.07 Mar/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Fujifilm JPY 60.69 5.53 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Ironwood Pharmaceuticals USD -0.01 0.25 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Myriad Genetics USD 0.04 0.01 Dec/2025
Pacira USD 0.06 0.64 Dec/2025
Perrigo USD 0.77 0.03 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025
Xencor USD -0.09 0.01 Dec/2025
Zoetis USD 1.48 0.22 Dec/2025